InterventionsHuman trial
Triple Therapy for Type 1 Diabetes with Insulin, Semaglutide, and Dapagliflozin (TTT1): A Phase 3 Clinical Trial
ADA Scientific Sessions 2026 Abstract
The paper
GHANIM HA, TIMMONS JG, GREENLAW N et al.
ADA Scientific Sessions 2026 Abstract · 5 Jun 2026
Presented at ADA Scientific Sessions 2026 · Late-breaking 2876-LB
